EDGAR Filing Documents for 0001176256-13-000237

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-13-000237

Filing Date

2013-04-15

Accepted

2013-04-15 11:26:16

Documents

Period of Report

2013-06-12

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR APRIL 15, 2012	nymox6kmpm130612.htm	6-K	5083
2	NOTICE OF ANNUAL GENERAL MEETING AND MANAGEMENT PROXY CIRCULAR	exhibit99-1.htm	EX-99.1	143538
3	FORM OF PROXY	exhibit99-2.htm	EX-99.2	22833
4		exhibit99-1x7x1.jpg	GRAPHIC	64691
5		exhibit99-2x1x1.jpg	GRAPHIC	3257
6		computersharelogo.jpg	GRAPHIC	2067
7		nymoxlogo.jpg	GRAPHIC	5145
	Complete submission text file	0001176256-13-000237.txt		276566

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 13760403
SIC: 2835 In Vitro & In Vivo Diagnostic Substances